Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization

Abstract Acute liver failure (ALF) is a life-threatening clinical syndrome with a substantial risk of mortality. A murine model of lipopolysaccharide (LPS)- and D-galactosamine (D-GalN)-induced ALF is widely used to investigate the underlying mechanisms and potential therapeutic drugs for human live...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Zhang, Min Gao, Haiyan Wang, Junfeng Zhang, Lin Wang, Guanjun Dong, Qun Ma, Chunxia Li, Jun Dai, Zhihua Li, Fenglian Yan, Huabao Xiong
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-86977-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571706329268224
author Hui Zhang
Min Gao
Haiyan Wang
Junfeng Zhang
Lin Wang
Guanjun Dong
Qun Ma
Chunxia Li
Jun Dai
Zhihua Li
Fenglian Yan
Huabao Xiong
author_facet Hui Zhang
Min Gao
Haiyan Wang
Junfeng Zhang
Lin Wang
Guanjun Dong
Qun Ma
Chunxia Li
Jun Dai
Zhihua Li
Fenglian Yan
Huabao Xiong
author_sort Hui Zhang
collection DOAJ
description Abstract Acute liver failure (ALF) is a life-threatening clinical syndrome with a substantial risk of mortality. A murine model of lipopolysaccharide (LPS)- and D-galactosamine (D-GalN)-induced ALF is widely used to investigate the underlying mechanisms and potential therapeutic drugs for human liver failure. Atractylenolide I (ATR-I) is an active component of the Atractylodes macrocephala rhizome and possesses various pharmacological activities, including anti-tumor, anti-inflammatory, and anti-oxidant properties. Given the key role of oxidative stress and inflammation in ALF pathogenesis, this study investigates the protective effects of ATR-I on LPS/D-GalN-induced ALF in mice. The results suggest that ATR-I pretreatment significantly ameliorates ALF, as evidenced by decreased serum aminotransferase levels and prolonged mice survival. Additionally, ATR-I pretreatment inhibits oxidative stress. Furthermore, the ATR-I pretreatment markedly suppresses M1 macrophage activation in hepatic mononuclear cells. In vitro experiments with bone marrow-derived macrophages indicate that ATR-I regulates macrophage polarization through the mitogen-activated protein kinase (MAPK) and interferon regulatory factor (IRF) signaling pathways. Collectively, ATR-I pretreatment protects mice from LPS/D-GalN-induced ALF partially by regulating M1 macrophage polarization.
format Article
id doaj-art-1c0ac6523b9e41d99e8ab1080c410029
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-1c0ac6523b9e41d99e8ab1080c4100292025-02-02T12:22:13ZengNature PortfolioScientific Reports2045-23222025-02-0115111510.1038/s41598-025-86977-xAtractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarizationHui Zhang0Min Gao1Haiyan Wang2Junfeng Zhang3Lin Wang4Guanjun Dong5Qun Ma6Chunxia Li7Jun Dai8Zhihua Li9Fenglian Yan10Huabao Xiong11Institute of Immunology and Molecular Medicine, Jining Medical UniversityClinical Laboratory, Jining First People’s HospitalInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityInstitute of Immunology and Molecular Medicine, Jining Medical UniversityAbstract Acute liver failure (ALF) is a life-threatening clinical syndrome with a substantial risk of mortality. A murine model of lipopolysaccharide (LPS)- and D-galactosamine (D-GalN)-induced ALF is widely used to investigate the underlying mechanisms and potential therapeutic drugs for human liver failure. Atractylenolide I (ATR-I) is an active component of the Atractylodes macrocephala rhizome and possesses various pharmacological activities, including anti-tumor, anti-inflammatory, and anti-oxidant properties. Given the key role of oxidative stress and inflammation in ALF pathogenesis, this study investigates the protective effects of ATR-I on LPS/D-GalN-induced ALF in mice. The results suggest that ATR-I pretreatment significantly ameliorates ALF, as evidenced by decreased serum aminotransferase levels and prolonged mice survival. Additionally, ATR-I pretreatment inhibits oxidative stress. Furthermore, the ATR-I pretreatment markedly suppresses M1 macrophage activation in hepatic mononuclear cells. In vitro experiments with bone marrow-derived macrophages indicate that ATR-I regulates macrophage polarization through the mitogen-activated protein kinase (MAPK) and interferon regulatory factor (IRF) signaling pathways. Collectively, ATR-I pretreatment protects mice from LPS/D-GalN-induced ALF partially by regulating M1 macrophage polarization.https://doi.org/10.1038/s41598-025-86977-xAcute liver failureAtractylenolide IM1 macrophage polarizationInflammationOxidative stress
spellingShingle Hui Zhang
Min Gao
Haiyan Wang
Junfeng Zhang
Lin Wang
Guanjun Dong
Qun Ma
Chunxia Li
Jun Dai
Zhihua Li
Fenglian Yan
Huabao Xiong
Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization
Scientific Reports
Acute liver failure
Atractylenolide I
M1 macrophage polarization
Inflammation
Oxidative stress
title Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization
title_full Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization
title_fullStr Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization
title_full_unstemmed Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization
title_short Atractylenolide I prevents acute liver failure in mouse by regulating M1 macrophage polarization
title_sort atractylenolide i prevents acute liver failure in mouse by regulating m1 macrophage polarization
topic Acute liver failure
Atractylenolide I
M1 macrophage polarization
Inflammation
Oxidative stress
url https://doi.org/10.1038/s41598-025-86977-x
work_keys_str_mv AT huizhang atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT mingao atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT haiyanwang atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT junfengzhang atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT linwang atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT guanjundong atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT qunma atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT chunxiali atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT jundai atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT zhihuali atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT fenglianyan atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization
AT huabaoxiong atractylenolideipreventsacuteliverfailureinmousebyregulatingm1macrophagepolarization